Thus, even though univariate analysis did not reveal any CSF C3 and FH level differences between MCI and mild AD, direct comparison of C3 and FH levels without accounting for effects from age and diagnosis at the patient and biomarker level – rather than at the model level – may have masked stage-dependent differences in C3 and FH levels. The gene discussed is C3; the disease is Alzheimer disease.